Regen Biopharma Inc (RGBP) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access RGBP Annual Balance Sheets →
The balance sheet figures below highlight longer-term patterns in how Regen Biopharma Inc finances operations and invests in assets.
Quarterly Report, GAAP in USD millions
ITEM
(Jun 30 2026)
(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Assets
Cash & cash equivalent0.00
Cash & Short-term Investments0.00
Accounts receivable0.29
Other Current Assets0.00
Prepaid Expense, Current AS0.00
Total Current Assets0.29
Long-term investments0.00
Tax Assets, Noncurrent4.68
Other Assets, Noncurrent0.00
Total Assets0.29
Liabilities
Accounts Payable, Current AC2.01
Accrued Liabilities, Current AC2.01
Derivative Liability LI1.90
Notes Payable, Current NO0.73
Other Liabilities, Current0.00
Deferred Revenue, Current DE1.24
Total Current Liabilities6.17
Convertible Notes Payable NO0.73
Total Long-term Debt0.73
Other liabilities, Noncurrent0.00
Convertible Note Payable Current0.82
Total Liabilities6.17
Stockholders' Equity
Common Stock Value0.11
Additional Paid In Capital Common Stock16.52
Retained Earnings / Accumulated Deficit-22.31
Accumulated Other Comprehensive Income-0.22
Other Equity-0.22
Common Stockholder's Equity-5.88
Total Stockholder's Equity-5.88
Liabilities & Stockholder's Equity0.29
4 historic quarters locked

Sign in to unlock the full Regen Biopharma Inc balance sheet history.

About Regen Biopharma Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-Q (Period: 20260630)
  • Filed with the SEC: August 17, 2026
  • Source: form10-q.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001493152-26-038576

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.